4basebio (4BB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

767.50p
   
  • Change Today:
    -17.50p
  • 52 Week High: 1,337.50
  • 52 Week Low: 703.85
  • Currency: UK Pounds
  • Shares Issued: 15.54m
  • Volume: 0
  • Market Cap: £119.26m

Broker Views

Show broker recommendations:
Show broker actions:
Date Broker name New Price Old price target New price target Broker change
02-Oct-25 RBC Capital Markets Outperform 775.00p 1,600.00p 1,600.00p Reiteration
13-Mar-25 RBC Capital Markets Outperform 1,115.00p - 1,600.00p Reiteration

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Consensus broker estimates sourced from FactSet Research Systems Inc., who calculate consensus using only those estimates changed or actively validated within the last 75 days.

 

4basebio Market Data

Currency UK Pounds
Share Price 767.50p
Change Today -17.50p
% Change -2.23 %
52 Week High 1,337.50
52 Week Low 703.85
Volume 0
Shares Issued 15.54m
Market Cap £119.26m

4basebio Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
65.49% below the market average65.49% below the market average65.49% below the market average65.49% below the market average65.49% below the market average
12.20% above the sector average12.20% above the sector average12.20% above the sector average12.20% above the sector average12.20% above the sector average
Price Trend
34.27% below the market average34.27% below the market average34.27% below the market average34.27% below the market average34.27% below the market average
4.55% above the sector average4.55% above the sector average4.55% above the sector average4.55% above the sector average4.55% above the sector average
Income Not Available
Growth
59.11% above the market average59.11% above the market average59.11% above the market average59.11% above the market average59.11% above the market average
65.52% above the sector average65.52% above the sector average65.52% above the sector average65.52% above the sector average65.52% above the sector average

4basebio Dividends

No dividends found

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

4basebio Key Personnel

CEO Heikki Lanckriet
CFO David John Roth

Top of Page